Clinical Trial Update: CGRP, Estrogen, Cortisol, VIP, α-Amylase, PGE2, PGI2 and ß-Endorphin Levels in Menstrual Migraine Before and After Treximet [Phase 4]

View source ↗

Summary

Phase 4 study evaluating biomarkers (CGRP, estrogen, cortisol, VIP, α-amylase, PGE2, PGI2, and β-endorphin) in menstrual migraine patients before and after trea…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Menstrual Migraine

Drugs mentioned

• TREXIMET (sumatriptan succinate and naproxen sodium)

Snippet

Sponsor: Cady, Roger, M.D. | Conditions: Menstrual Migraine | Phase 4 | Status: COMPLETED | Results posted: 2014-04-09